1) T assistant lymphocyte subset
T辅助淋巴细胞亚群
2) T-helper lymphocyte subsets
辅助性T淋巴细胞亚群
1.
Changes of T-helper lymphocyte subsets in children with primary nephrotic syndrome;
儿童原发性肾病综合征外周血辅助性T淋巴细胞亚群的变化
3) T helper cell
T辅助淋巴细胞
1.
The out-balance of T helper cell subsets in ALI and the regulative function of tripchrolide;
雷公藤氯内酯醇对急性肺损伤患者T辅助淋巴细胞功能的调节作用体外研究
4) T-lymphocyte subsets
T淋巴细胞亚群
1.
Application of T-lymphocyte subsets detection for the differential diagnosis between acute rejection and cyclosporine A toxicities after renal transplantation;
T淋巴细胞亚群检测在肾移植排斥反应与环孢霉素A中毒鉴别诊断中的应用
2.
Effects of the T-lymphocyte subsets and NK cells induced by retinoic acid on the hepatocarcinoma in rat;
维甲酸对DENA诱发肝癌大鼠的T淋巴细胞亚群与NK细胞的影响
3.
Effects of general anesthesia combined with high thoracic epidural block on T-lymphocyte subsets in patients undergoing off-pump coronary artery bypass surgery;
全麻复合胸段硬膜外阻滞对不停跳冠状动脉搭桥术后患者T淋巴细胞亚群的影响
5) T lymphocyte subgroup
T淋巴细胞亚群
1.
Determination of platelet-associated immunoglobulin and T lymphocyte subgroups in patients with idiopathic thrombocytopenic purpura by flow cytometry;
流式细胞术检测特发性血小板减少性紫癜患者血小板相关免疫球蛋白及T淋巴细胞亚群
2.
The effect of Zhongjiling tablet on T lymphocyte subgroup of ⅡA type myasthenia gravis patients and the level of IFN-γ,IL-4 and TGF-β;
重肌灵片对ⅡA型重症肌无力外周血T淋巴细胞亚群及细胞因子IFN-γ、IL-4、TGF-β水平的影响
3.
Assay of T lymphocyte subgroup and immunoglobulin state in peripheral blood of patients with primary extranodal lymphoma;
淋巴结外恶性淋巴瘤外周血T淋巴细胞亚群与免疫指标测定分析
6) T lymphocyte subset
T淋巴细胞亚群
1.
Influence of cardiopulmonary bypass on T lymphocyte subsets in infant during open heart surgery;
体外循环心脏直视手术对小儿T淋巴细胞亚群的影响
2.
Effect of different extracts of Caesalpinia Sappan L on T lymphocyte subsets and myocardial protectively function after rat heart transplantation;
苏木提取物对心脏移植大鼠T淋巴细胞亚群的免疫抑制和对心肌的保护作用
3.
Analysis of distribution of T lymphocyte subsets in patients with acute leukemia;
急性白血病患者T淋巴细胞亚群的分布探讨
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条